EODData

OTCBB, USRM: US Stem Cell

24 Nov 2025
LAST:

0.0001

CHANGE:
 0.00
OPEN:
0.0001
HIGH:
0.0001
ASK:
0.0000
VOLUME:
86.6K
CHG(%):
0.00
PREV:
0.0001
LOW:
0.0001
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Nov 250.00010.00010.00010.000186.6K
17 Nov 250.00010.00010.00010.00011.06M
10 Nov 250.00010.00010.00010.00012.0M
07 Nov 250.00010.00010.00010.000160.0K

PROFILE

Name:US Stem Cell
About:U.S. Stem Cell, Inc., a biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States. The company's lead product candidates include MyoCell, a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells or cells from a patient's body for enhancing cardiac function in chronic heart failure patients; and AdipoCell, a patient-derived cell therapy for the treatment of acute myocardial infarction, chronic heart ischemia, and lower limb ischemia. Its pipeline products include MyoCell SDF-1, an autologous muscle-derived cellular therapy for enhancing cardiac function in chronic heart failure patients. The company is also developing MyoCath, a deflecting tip needle injection catheter that is used to inject cells into cardiac tissue in therapeutic procedures to treat chronic heart ischemia and congestive heart failure. In addition, it provides physician and patient based regenerative medicine/cell therapy training, cell collection, and cell storage services; and cell collection and treatment kits for humans and animals, as well as operates a cell therapy clinic to provide cellular treatments for patients afflicted with neurological, autoimmune, orthopedic, and degenerative diseases. The company also offers various courses for physicians and other health care professionals. The company was formerly known as Bioheart, Inc. and changed its name to U.S. Stem Cell, Inc. in October 2015. U.S. Stem Cell, Inc. was incorporated in 1999 and is headquartered in Sunrise, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:1560 Sawgrass Corporate Parkway, Sunrise, FL, United States, 33323
Website:https://www.us-stemcell.com
CUSIP:90350U100
CIK:0001388319
ISIN:US90350U1007
FIGI:BBG000R0ZM84
LEI:549300BYV51UWQXOKZ83

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.000.0%
MA10:0.000.0%
MA20:0.000.0%
MA50:0.000.0%
MA100:0.000.0%
Week High:0.000.0%
Week Low:0.000.0%
Month High:0.000.0%
Month Low:0.00
Volatility:247.99